(Q36779665)

16 August 2017

1 reference

title

Lisdexamfetamine. (English)

1 reference

16 August 2017

2

Gillian M Keating

1 reference

16 August 2017

Stephanie K A Blick

1

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

129-35; discussion 136-8

1 reference

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

16 August 2017

cites work

1 reference

12 December 2020

Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices

1 reference

12 December 2020

An evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomes.

1 reference

12 December 2020

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential

1 reference

12 December 2020

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration

1 reference

12 December 2020

Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention

1 reference

12 December 2020

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

1 reference

12 December 2020

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

1 reference

12 December 2020

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

1 reference

12 December 2020

10.2165/00148581-200709020-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1038029506

0 references

1 reference